default author photo

Kathleen Burke

Tempus AI, Inc.

Boston, MA

United States

SCHOLARLY PAPERS

1

DOWNLOADS

38

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Pan-Cancer Analysis in the Real-World Setting Uncovers Immunogenomic Drivers of Acquired Resistance Post-Immunotherapy

Number of pages: 52 Posted: 30 Jul 2025
Mohamed Reda Keddar, Sebastian Carrasco Pro, Roy Rabbie, Zeynep Kalender Atak, Ana Camelo Stewart, Scott A. Hammond, Douglas C. Palmer, Ross Stewart, Kathleen Burke, Ben Sidders, Jessica Davies, Jonathan Dry, Inigo Martincorena, Sajan Khosla, Adam J. Schoenfeld, Martin L. Miller and Sneak Peek Administrator
AstraZeneca Pharmaceuticals - UK, Boehringer Ingelheim Pharmaceuticals Inc, AstraZeneca Pharmaceuticals - UK, Quotient Therapeutics Inc, AstraZeneca Pharmaceuticals - UK, AstraZeneca Pharmaceuticals - AstraZeneca R&D, AstraZeneca Pharmaceuticals - AstraZeneca R&D, AstraZeneca Pharmaceuticals - UK, Tempus AI, Inc., Biorelate Ltd, AstraZeneca Farmaceutica Spain SA, Tempus AI, Inc., Wellcome Sanger Institute, AstraZeneca Pharmaceuticals - UK, Memorial Sloan Kettering Cancer Center, AstraZeneca Pharmaceuticals - UK and Independent
Downloads 38 (1,236,159)

Abstract:

Loading...

cancer immunotherapy, acquired resistance, immunogenomics, real-world data